The public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. This Phase II proposal (G. Tononi-PI) resulted from the combination of two independent projects in Phase I: "Rapid discovery of continuous performance and power-nap compounds through large-scale mutagenesis in Drosophila" (G. Tononi-PI, C. Cirelli-CoPI) and "Avian models of sustained wakefulness" (R. Benca-PI, N. Rattenborg-CoPI). The goal of both projects was to find ways to postpone temporarily the need for sleep, and do so in a way that is completely safe. In Phase I, the strategy had been to study animal models of sleeplessness, including models created through mutagenesis (flies) or naturally-occurring models (birds), in order to identify druggable targets that can be exploited to produce prolonged 
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From 24/7 flies and birds to 24/7 humans: The University of Wisconsin Continuous Performance Project Ruth Benca, Chiara Cirelli, Giulio Tononi
STATEMENT OF THE PROBLEM STUDIED
This Phase II proposal resulted from the combination of two independent projects in Phase I: "Rapid discovery of continuous performance and power-nap compounds through large-scale mutagenesis in Drosophila" (G. Tononi-PI, C. Cirelli-CoPI) and "Avian models of sustained wakefulness" (R. Benca-PI, N. Rattenborg-CoPI). The goal of both of these projects was to find ways to postpone temporarily the need for sleep, and do so in a way that is completely safe. The strategy for both projects has been to study animal models of sleeplessness, including models created through mutagenesis (flies) or naturally-occurring models (birds), in order to identify druggable targets that can be exploited to produce prolonged wakefulness in the absence of performance decrements or health risks. During Phase I, we demonstrated in both projects that models exist or can be produced that fully meet the goals of the CAP initiative. By using large-scale mutagenesis in flies, we have discovered some lines that need minimal amounts of sleep and yet perform impeccably. Moreover, for several of these lines we have identified the responsible genes, opening the way to targeted drug development. By studying migratory birds, we have shown that, during migration, birds can dramatically restrict their need for sleep for several days and yet carry out their tasks flawlessly. We have also found specific transcripts that are upregulated in their brains during migration, which will also lead to the identification of potential drug targets.
The overall goals for Phase II was to characterize the mechanisms for these models and determine how to switch them on safely in humans. Based on discussions with DARPA at the June 2003 Downselection Meeting, we selected to combine the two projects in Phase II for two reasons: (1) The overall approach for each model, which was to determine the specific mechanisms and genes responsible for sleep reduction and then to develop drugs that can produce temporary sleeplessness, was generally the same; and (2) It was likely that responsible genes were similar in the various models, which could not only suggest the most likely targets to pursue, but also reduce duplication of efforts.
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The Phase II proposal was therefore structured along 3 subprojects and 3 tasks: 
SUBPROJECTS
Task 2
• Complete screening of compound libraries against potassium channel targets and nicotinic agonists, selectivity profiling • Physiochem, ADMET, and wide profiling testing for potassium channel compounds and nicotinic agonists
Task 3
• Scaled up apparatus for testing drug effects on sleep/waking -vigilance in rats • Tested candidate compounds for effects on sleep/waking and performance in rats: results for potassium channel compounds have been published or presented in abstract form at scientific meetings Faraguna et al., 2006) ; results for nicotinic agents have been presented in abstract form at scientific meetings (Faraguna et al., 2007) 
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